ATE478945T1 - Virus enthaltende zusammensetzungen und methoden zur konzentration von viruspräparaten - Google Patents
Virus enthaltende zusammensetzungen und methoden zur konzentration von viruspräparatenInfo
- Publication number
- ATE478945T1 ATE478945T1 AT06019642T AT06019642T ATE478945T1 AT E478945 T1 ATE478945 T1 AT E478945T1 AT 06019642 T AT06019642 T AT 06019642T AT 06019642 T AT06019642 T AT 06019642T AT E478945 T1 ATE478945 T1 AT E478945T1
- Authority
- AT
- Austria
- Prior art keywords
- virus
- concentration
- methods
- containing compositions
- preparations
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10351—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2446298A | 1998-02-17 | 1998-02-17 | |
| US7964398A | 1998-05-15 | 1998-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE478945T1 true ATE478945T1 (de) | 2010-09-15 |
Family
ID=26698472
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99906690T ATE341614T1 (de) | 1998-02-17 | 1999-02-12 | Virus enthaltende zusammensetzungen und methoden zur konzentration von viruspräparaten |
| AT04030395T ATE371020T1 (de) | 1998-02-17 | 1999-02-12 | Virusenthaltende zusammensetzungen und methoden zur konzentration von viruspräparaten |
| AT06019642T ATE478945T1 (de) | 1998-02-17 | 1999-02-12 | Virus enthaltende zusammensetzungen und methoden zur konzentration von viruspräparaten |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99906690T ATE341614T1 (de) | 1998-02-17 | 1999-02-12 | Virus enthaltende zusammensetzungen und methoden zur konzentration von viruspräparaten |
| AT04030395T ATE371020T1 (de) | 1998-02-17 | 1999-02-12 | Virusenthaltende zusammensetzungen und methoden zur konzentration von viruspräparaten |
Country Status (24)
| Country | Link |
|---|---|
| EP (4) | EP1526174B1 (de) |
| JP (3) | JP4358434B2 (de) |
| KR (5) | KR100918187B1 (de) |
| CN (2) | CN101164623B (de) |
| AR (3) | AR020054A1 (de) |
| AT (3) | ATE341614T1 (de) |
| AU (1) | AU757976B2 (de) |
| BR (1) | BR9908015A (de) |
| CA (2) | CA2320419C (de) |
| CO (1) | CO4820440A1 (de) |
| DE (3) | DE69942708D1 (de) |
| DK (1) | DK1054955T3 (de) |
| ES (2) | ES2290613T3 (de) |
| HU (1) | HU226015B1 (de) |
| ID (1) | ID28298A (de) |
| IL (2) | IL137510A0 (de) |
| MY (1) | MY141641A (de) |
| NO (1) | NO20004104L (de) |
| PE (1) | PE20000265A1 (de) |
| PL (1) | PL197747B1 (de) |
| PT (1) | PT1054955E (de) |
| SK (1) | SK11842000A3 (de) |
| TW (1) | TWI232107B (de) |
| WO (1) | WO1999041416A2 (de) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0968284B1 (de) | 1996-11-20 | 2006-12-13 | Introgen Therapeutics, Inc. | Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren |
| US7732129B1 (en) | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
| US6689600B1 (en) | 1998-11-16 | 2004-02-10 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
| EP1133316B1 (de) * | 1998-11-16 | 2009-01-21 | Introgen Therapeutics, Inc. | Adenovirus-formulierungen zur gentherapie |
| US7456009B2 (en) | 2000-03-07 | 2008-11-25 | Merck & Co., Inc. | Adenovirus formulations |
| EP2420247A1 (de) | 2000-03-07 | 2012-02-22 | Merck Sharp & Dohme Corp. | Adenovirus-Formulierungen |
| US20020064860A1 (en) | 2000-11-29 | 2002-05-30 | Schering Corporation | Method for purifying adenoviruses |
| WO2002047726A2 (en) * | 2000-12-12 | 2002-06-20 | Japan Tobacco Inc. | Pharmaceutical composition containing an active with a hemolytic action and a surfactant |
| CA2469491A1 (en) | 2001-12-12 | 2003-06-19 | Kerrie Setiawan | Composition for viral preservation |
| US20030153065A1 (en) * | 2002-01-14 | 2003-08-14 | Genvec, Inc. | Composition and method for maintaining non-enveloped viral vectors |
| US20030232018A1 (en) * | 2002-01-18 | 2003-12-18 | Berlex Biosciences | Stabilized formulations of adenovirus |
| CN1922308A (zh) | 2004-02-23 | 2007-02-28 | 克鲁塞尔荷兰公司 | 病毒纯化方法 |
| CN101080488A (zh) | 2004-11-03 | 2007-11-28 | 因特罗根治疗公司 | 生产和纯化腺病毒载体的新方法 |
| WO2006065827A2 (en) | 2004-12-13 | 2006-06-22 | Canji, Inc. | Cell lines for production of replication-defective adenovirus |
| ATE412737T1 (de) | 2005-04-11 | 2008-11-15 | Crucell Holland Bv | Virusreinigung mit ultrafiltration |
| CN1961961B (zh) * | 2005-11-11 | 2010-05-26 | 深圳市源兴生物医药科技有限公司 | 一种药物制剂及其制备方法 |
| EP1974044B1 (de) | 2005-12-12 | 2011-01-26 | CANJI, Inc. | Adenovirale expressionsvektoren mit einer expressionskassette im e1-bereich und einer inaktivierten e2b-polymerase |
| PL2007883T3 (pl) * | 2006-04-20 | 2012-07-31 | Wyeth Llc | Sposób oczyszczania do izolacji oczyszczonego wirusa pęcherzykowatego zapalenia jamy ustnej z hodowli komórkowej |
| EA019928B1 (ru) | 2008-11-03 | 2014-07-30 | Круселл Холланд Б.В. | Способ получения аденовирусных векторов |
| SI3988660T1 (sl) | 2009-05-02 | 2025-09-30 | Genzyme Corporation | Genska terapija za nevrodegenerativne motnje |
| PL2536829T3 (pl) | 2010-02-15 | 2016-09-30 | Sposób wytwarzania wektorów adenowirusowych Ad26 | |
| CA2808556A1 (en) | 2010-09-20 | 2012-03-29 | Crucell Holland B.V. | Therapeutic vaccination against active tuberculosis |
| BR112013004582A2 (pt) | 2010-09-27 | 2016-09-06 | Crucell Holland Bv | método para induzir uma resposta imune em um sujeito contra um antígeno de um parasita que causa a malária |
| CA2819236A1 (en) | 2010-12-02 | 2012-06-07 | Oncolytics Biotech Inc. | Lyophilized viral formulations |
| MX373096B (es) | 2010-12-02 | 2020-04-27 | Oncolytics Biotech Inc | Formulaciones virales líquidas. |
| EA201391605A1 (ru) * | 2011-04-29 | 2014-02-28 | Онколитикс Байотек Инк. | Способы очистки вирусов с использованием гельпроникающей хроматографии |
| US8932607B2 (en) | 2012-03-12 | 2015-01-13 | Crucell Holland B.V. | Batches of recombinant adenovirus with altered terminal ends |
| KR102044051B1 (ko) | 2012-03-12 | 2019-11-12 | 얀센 백신스 앤드 프리벤션 비.브이. | 터미널 말단이 변경된 재조합 아데노바이러스의 배치 |
| JP5845376B2 (ja) | 2012-03-22 | 2016-01-20 | クルセル ホランド ベー ヴェー | Rsvに対するワクチン |
| US9125870B2 (en) | 2012-03-22 | 2015-09-08 | Crucell Holland B.V. | Vaccine against RSV |
| PT2988780T (pt) | 2013-04-25 | 2019-03-25 | Janssen Vaccines & Prevention Bv | Polipeptídeos f de pré-fusão do rsv solúveis estabilizados |
| CN105408348B (zh) | 2013-06-17 | 2021-07-06 | 扬森疫苗与预防公司 | 稳定化的可溶性融合前rsv f多肽 |
| SG11201609908VA (en) * | 2014-05-28 | 2016-12-29 | Agency Science Tech & Res | Virus reduction method |
| AU2016249798B2 (en) | 2015-04-14 | 2022-05-26 | Janssen Vaccines And Prevention B.V. | Recombinant adenovirus expressing two transgenes with a bidirectional promoter |
| AU2016289496B2 (en) | 2015-07-07 | 2021-02-04 | Janssen Vaccines & Prevention B.V. | Stabilized soluble pre-fusion RSV F polypeptides |
| CN107847580B (zh) | 2015-07-07 | 2022-08-12 | 扬森疫苗与预防公司 | 针对rsv的疫苗 |
| AU2017248018A1 (en) | 2016-04-05 | 2018-09-27 | Janssen Vaccines & Prevention B.V. | Vaccine against RSV |
| MX2018012094A (es) | 2016-04-05 | 2019-01-10 | Janssen Vaccines & Prevention Bv | Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas. |
| SG11201810078PA (en) | 2016-05-30 | 2018-12-28 | Janssen Vaccines & Prevention Bv | Stabilized pre-fusion rsv f proteins |
| US11001858B2 (en) | 2016-06-20 | 2021-05-11 | Janssen Vaccines & Prevention B.V. | Potent and balanced bidirectional promoter |
| US10744196B2 (en) | 2016-07-14 | 2020-08-18 | Janssen Vaccines & Prevention B.V. | HPV vaccines |
| CA3061278A1 (en) | 2017-05-17 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against rsv infection |
| WO2018210871A1 (en) | 2017-05-17 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against rsv infection |
| WO2019021305A1 (en) * | 2017-07-24 | 2019-01-31 | Ella Foundation | VACCINE AGAINST FOOT AND MOUTH DISEASE |
| AU2018333566A1 (en) | 2017-09-15 | 2020-02-27 | Janssen Vaccines & Prevention B.V. | Method for the safe induction of immunity against RSV |
| PE20211469A1 (es) | 2018-11-13 | 2021-08-05 | Janssen Vaccines And Prevention B V | Proteinas f de prefusion del vrs estabilizadas |
| US20220267796A1 (en) * | 2019-06-28 | 2022-08-25 | Takeda Pharmaceutical Company Limited | Adeno-associated virus purification methods |
| TW202204380A (zh) | 2020-01-31 | 2022-02-01 | 美商詹森藥物公司 | 用於預防及治療冠狀病毒感染之組合物及方法-sars-cov-2疫苗 |
| CN115484985A (zh) * | 2020-03-19 | 2022-12-16 | 崔泽尔有限公司 | 温度响应病毒储存系统 |
| US20240228548A9 (en) | 2021-02-19 | 2024-07-11 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion rsv fb antigens |
| WO2023020939A1 (en) | 2021-08-17 | 2023-02-23 | Janssen Pharmaceuticals, Inc. | Sars-cov-2 vaccines |
| WO2023020556A1 (zh) * | 2021-08-17 | 2023-02-23 | 上海行深生物科技有限公司 | 病毒制剂、用于配制病毒制剂的溶液及其用途 |
| WO2023111725A1 (en) | 2021-12-14 | 2023-06-22 | Janssen Pharmaceuticals, Inc. | Sars-cov-2 vaccines |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE299213C (de) * | ||||
| US4147772A (en) * | 1976-02-03 | 1979-04-03 | Merck & Co., Inc. | Vaccine stabilizer |
| GB1575155A (en) * | 1978-04-11 | 1980-09-17 | Merck & Co Inc | Vaccine stabilizer |
| BE866330A (fr) * | 1978-04-25 | 1978-10-25 | Merck & Co Inc | Procede de fabrication d'un agent de stabilisation de vaccin |
| US5532220A (en) | 1987-08-31 | 1996-07-02 | The Regents Of The University Of California | Genetic mechanisms of tumor suppression |
| DD299213A7 (de) * | 1988-05-04 | 1992-04-09 | Saechsische Landesgewerbefoerderungsgesellschaft M.B.H.,De | Verfahren zur stabilisierung eines lebendvirusimpfstoffes gegen temperatureinwirkung |
| DD295927A5 (de) * | 1988-05-06 | 1991-11-14 | Saechsisches Serumwerk Gmbh Dresden, | Immobilisiertes immunologisch aktives reagens |
| DE69435223D1 (de) | 1993-10-25 | 2009-09-03 | Canji Inc | Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung |
| KR100368686B1 (ko) * | 1994-12-29 | 2003-12-01 | 주식회사 엘지생명과학 | 수크로즈를이용한세포와바이러스의분리방법 |
| FR2742756B1 (fr) * | 1995-12-22 | 1998-04-03 | Pasteur Merieux Serums Vacc | Stabilisants pour vaccins vivants, vaccins les contenant et procedes pour leur preparation |
| US5789244A (en) * | 1996-01-08 | 1998-08-04 | Canji, Inc. | Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems |
-
1999
- 1999-02-12 KR KR1020087008929A patent/KR100918187B1/ko not_active Expired - Fee Related
- 1999-02-12 IL IL13751099A patent/IL137510A0/xx unknown
- 1999-02-12 WO PCT/US1999/001873 patent/WO1999041416A2/en not_active Ceased
- 1999-02-12 CN CN2007101670867A patent/CN101164623B/zh not_active Expired - Fee Related
- 1999-02-12 JP JP2000531596A patent/JP4358434B2/ja not_active Expired - Fee Related
- 1999-02-12 ES ES04030395T patent/ES2290613T3/es not_active Expired - Lifetime
- 1999-02-12 AT AT99906690T patent/ATE341614T1/de not_active IP Right Cessation
- 1999-02-12 CA CA2320419A patent/CA2320419C/en not_active Expired - Fee Related
- 1999-02-12 DE DE69942708T patent/DE69942708D1/de not_active Expired - Lifetime
- 1999-02-12 AT AT04030395T patent/ATE371020T1/de not_active IP Right Cessation
- 1999-02-12 EP EP04030395A patent/EP1526174B1/de not_active Expired - Lifetime
- 1999-02-12 PT PT99906690T patent/PT1054955E/pt unknown
- 1999-02-12 BR BR9908015-0A patent/BR9908015A/pt not_active Application Discontinuation
- 1999-02-12 AT AT06019642T patent/ATE478945T1/de not_active IP Right Cessation
- 1999-02-12 KR KR1020097004676A patent/KR100991683B1/ko not_active Expired - Fee Related
- 1999-02-12 PL PL342847A patent/PL197747B1/pl not_active IP Right Cessation
- 1999-02-12 DE DE69933433T patent/DE69933433T2/de not_active Expired - Lifetime
- 1999-02-12 HU HU0100670A patent/HU226015B1/hu not_active IP Right Cessation
- 1999-02-12 KR KR1020087008928A patent/KR100912362B1/ko not_active Expired - Fee Related
- 1999-02-12 ES ES99906690T patent/ES2272053T3/es not_active Expired - Lifetime
- 1999-02-12 TW TW088102219A patent/TWI232107B/zh not_active IP Right Cessation
- 1999-02-12 KR KR1020007008878A patent/KR100862169B1/ko not_active Expired - Fee Related
- 1999-02-12 CN CNB998050989A patent/CN100374551C/zh not_active Expired - Fee Related
- 1999-02-12 AU AU26538/99A patent/AU757976B2/en not_active Ceased
- 1999-02-12 DE DE69936948T patent/DE69936948T2/de not_active Expired - Lifetime
- 1999-02-12 CA CA2723040A patent/CA2723040A1/en not_active Abandoned
- 1999-02-12 SK SK1184-2000A patent/SK11842000A3/sk unknown
- 1999-02-12 ID IDW20001574A patent/ID28298A/id unknown
- 1999-02-12 EP EP06019642A patent/EP1741777B1/de not_active Expired - Lifetime
- 1999-02-12 EP EP99906690A patent/EP1054955B1/de not_active Expired - Lifetime
- 1999-02-12 DK DK99906690T patent/DK1054955T3/da active
- 1999-02-12 KR KR1020097022935A patent/KR101018992B1/ko not_active Expired - Fee Related
- 1999-02-12 EP EP04030394A patent/EP1526173B1/de not_active Expired - Lifetime
- 1999-02-15 MY MYPI99000542A patent/MY141641A/en unknown
- 1999-02-16 PE PE1999000137A patent/PE20000265A1/es not_active Application Discontinuation
- 1999-02-16 CO CO99009282A patent/CO4820440A1/es unknown
- 1999-02-23 AR ARP990100656A patent/AR020054A1/es active IP Right Grant
-
2000
- 2000-07-25 IL IL137510A patent/IL137510A/en not_active IP Right Cessation
- 2000-08-16 NO NO20004104A patent/NO20004104L/no not_active Application Discontinuation
-
2006
- 2006-02-07 JP JP2006030336A patent/JP2006166925A/ja not_active Withdrawn
-
2007
- 2007-10-16 AR ARP070104577A patent/AR063315A2/es unknown
- 2007-10-16 AR ARP070104576A patent/AR063314A2/es unknown
-
2010
- 2010-07-08 JP JP2010156257A patent/JP2010213727A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE341614T1 (de) | Virus enthaltende zusammensetzungen und methoden zur konzentration von viruspräparaten | |
| EP1254267A4 (de) | Zusammensetzungen und methoden zur früherkennung von eierstockkrebs | |
| DE69737793D1 (de) | Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs | |
| DE69837703D1 (de) | Methoden zum nachweis und zur analyse von virus | |
| DE69942680D1 (de) | Verfahren und Zusammensetzungen zur Prävention und Behandlung von Anämie | |
| ATE478138T1 (de) | Verfahren zur inaktivierung von lipidumhüllten viren | |
| EP1324780A4 (de) | Methoden zur behandlung von herzarrhythmie | |
| DE69921853D1 (de) | Vorrichtung zur behandlung von abgas | |
| EP1328284A4 (de) | Neue medizinische kräuterzusammensetzung zur behandlung von lebererkrankungen und hiv | |
| DE69934877D1 (de) | Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen | |
| DE69327755D1 (de) | Zusammensetzung zum Unterdrücken von Infektion und Wachstum des menschlichen Immunschwäche-Virus unter Verwendung eines eisenbindenden Proteins | |
| DE69932845D1 (de) | Methoden zur quantifizierung von hla-dr und cd11b | |
| EP1052988A4 (de) | Methoden und zusammenstellungen zur inaktivierung von viren | |
| EP0569703A3 (de) | Verfahren zur Behandlung und Verhütung viraler Infektionen unter Verwendung von HBNF und MK Protein. | |
| EP1162934A4 (de) | Zusammensetzungen und vefahren zur vorbeugung von lichtalterung | |
| DE60017341D1 (de) | Emulsion, und Verfahren zur Herstellung von Emulsionen und öligen Zusammensetzungen | |
| DE69935326D1 (de) | Zusammensetzungen enthaltend molybden zur steigerung des proteinanabolismus und der entgiftung | |
| DE69933121D1 (de) | Methode, reagent und testsatz zur typisierung des genoms von papillomavirus | |
| DE60222233D1 (de) | Prozessor und Verfahren zur Erhaltung der Verarbeitungsreihenfolge von Paketen basierend auf Paketstromkennungen | |
| DE69631443D1 (de) | Reagens zur untersuchung von viren-agglutination und kit zur untersuchung auf viren | |
| DE69941317D1 (de) | Verfahren zur Untersuchung von Gasen | |
| ATE211928T1 (de) | Verfahren zur inaktivierung von viren in proteinen | |
| DE59905059D1 (de) | Verfahren zur Herstellung von Hydroxyethylcyclohexanen und Hydroxyethylpiperidinen | |
| DE69830156D1 (de) | Zusammensetzungen zur immunverstärkung von impfstoffen | |
| EP1181050A4 (de) | Methoden zur verhinderung der reaktivierung von latenten viren und zur kontrolleder virusreplikation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |